FDA backs Pfizer COVID-19 boosters for seniors, high-risk
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others …
Home »
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others …
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization …
FILE PHOTO: Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, …
(HealthDay)—The Pfizer and Moderna vaccines trigger an immune system response that could fend off the coronavirus for years to come, …
FILE PHOTO: Family members look on as Jack Frilingos, 12, is inoculated with Pfizer’s vaccine against coronavirus disease (COVID-19) after …
(Reuters) -The European Commission on Friday authorized Pfizer and partner BioNTech SE’s COVID-19 vaccine for use in children as young …
Europe’s medicines watchdog said Friday it was checking whether COVID-19 vaccines made by Pfizer/BioNTech and Moderna could be linked to …
AstraZeneca: James Dyson praises 'world beating' UK vaccine When you subscribe we will use the information you provide to send …
WASHINGTON (Reuters) – The White House welcomed Pfizer Inc’s announcement on Wednesaday that its COVID-19 vaccine was safe and effective …
(HealthDay)—The two-dose mRNA vaccines from Pfizer and Moderna have proven to be potent weapons against COVID-19 infection among health care …
Pfizer has agreed to move up deliveries of its COVID-19 vaccine to Canada, Prime Minister Justin Trudeau said Tuesday, one …
AstraZeneca: Expert doubts EU ability to rebuild public trust When you subscribe we will use the information you provide to …
Brazil has ordered 100 million doses of the Pfizer-BioNTech COVID-19 vaccine and another 38 million of Johnson & Johnson’s, the …
New data from Addenbrooke’s Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by …
“Pfizer and Moderna could share their design with dozens of other pharma companies who stand ready to produce their vaccines …
(HealthDay)—Despite scattered media reports of severe allergic reactions to the Pfizer COVID-19 vaccine, a detailed analysis shows that such incidents …
Pfizer and BioNTech will supply the U.S. with an additional 100 million doses of their COVID-19 vaccine under a second …
The Pfizer/BioNTech vaccine for COVID-19 has reached the end of clinical trials and is now being rolled out in multiple …